Cytodyn Inc (CYDY)

[finesand]

2017 March Presentation p20, while stretching the timeline a bit saying 2H17 (2Q17) instead of 1Q17, they are still on track.
Combo primary and the Mono-Part1(100 pt safety) is targeted together for 2Q17. Also 2 publications for ASM. Hopefully they have enrolled much more than one patient for mono so far. Maybe they will disclose some more details at the next CC. A little eastern egg for all of us, if lucky :)
BTD + ODD now expected in 2H17 for Mono BLA, probably, using existing data. Sensible.
April - June 2017 might deliver some significant event according to this schedule. After waiting much longer already, this final period seems like a nice hike.